These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

631 related articles for article (PubMed ID: 28479486)

  • 1. Integrated Diagnosis Project for Inflammatory Myopathies: An association between autoantibodies and muscle pathology.
    Suzuki S; Uruha A; Suzuki N; Nishino I
    Autoimmun Rev; 2017 Jul; 16(7):693-700. PubMed ID: 28479486
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Autoantibodies of Inflammatory Myopathies: Update].
    Suzuki S
    Brain Nerve; 2016 Dec; 68(12):1443-1451. PubMed ID: 27916754
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Antisynthetase myopathy].
    Suzuki S
    Rinsho Shinkeigaku; 2020 Mar; 60(3):175-180. PubMed ID: 32101845
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Skeletal Muscle Involvement in Antisynthetase Syndrome.
    Noguchi E; Uruha A; Suzuki S; Hamanaka K; Ohnuki Y; Tsugawa J; Watanabe Y; Nakahara J; Shiina T; Suzuki N; Nishino I
    JAMA Neurol; 2017 Aug; 74(8):992-999. PubMed ID: 28586844
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potential Pathogenic Role of Anti-Signal Recognition Protein and Anti-3-hydroxy-3-methylglutaryl-CoA Reductase Antibodies in Immune-Mediated Necrotizing Myopathies.
    Ladislau L; Arouche-Delaperche L; Allenbach Y; Benveniste O
    Curr Rheumatol Rep; 2018 Aug; 20(9):56. PubMed ID: 30074107
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immune-mediated necrotizing myopathy (IMNM): A myopathological challenge.
    Merlonghi G; Antonini G; Garibaldi M
    Autoimmun Rev; 2022 Feb; 21(2):102993. PubMed ID: 34798316
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of a New Classification System for Idiopathic Inflammatory Myopathies Based on Clinical Manifestations and Myositis-Specific Autoantibodies.
    Mariampillai K; Granger B; Amelin D; Guiguet M; Hachulla E; Maurier F; Meyer A; Tohmé A; Charuel JL; Musset L; Allenbach Y; Benveniste O
    JAMA Neurol; 2018 Dec; 75(12):1528-1537. PubMed ID: 30208379
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Myositis-specific autoantibodies].
    Fujimoto M
    Brain Nerve; 2013 Apr; 65(4):449-60. PubMed ID: 23568993
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-Jo-1 antibody-positive patients show a characteristic necrotizing perifascicular myositis.
    Mescam-Mancini L; Allenbach Y; Hervier B; Devilliers H; Mariampillay K; Dubourg O; Maisonobe T; Gherardi R; Mezin P; Preusse C; Stenzel W; Benveniste O
    Brain; 2015 Sep; 138(Pt 9):2485-92. PubMed ID: 26198592
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peculiar clinicopathological features of immune-mediated necrotizing myopathies.
    Allenbach Y; Benveniste O
    Curr Opin Rheumatol; 2018 Nov; 30(6):655-663. PubMed ID: 30239349
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nuclear actin aggregation is a hallmark of anti-synthetase syndrome-induced dysimmune myopathy.
    Stenzel W; Preuße C; Allenbach Y; Pehl D; Junckerstorff R; Heppner FL; Nolte K; Aronica E; Kana V; Rushing E; Schneider U; Claeys KG; Benveniste O; Weis J; Goebel HH
    Neurology; 2015 Mar; 84(13):1346-54. PubMed ID: 25746564
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Diagnosis of Idiopathic Inflammatory Myopathy: A Muscle Pathology Perspective].
    Inoue M; Nishino I
    Brain Nerve; 2016 Dec; 68(12):1431-1441. PubMed ID: 27916753
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Redefining dermatomyositis: a description of new diagnostic criteria that differentiate pure dermatomyositis from overlap myositis with dermatomyositis features.
    Troyanov Y; Targoff IN; Payette MP; Raynauld JP; Chartier S; Goulet JR; Bourré-Tessier J; Rich E; Grodzicky T; Fritzler MJ; Joyal F; Koenig M; Senécal JL
    Medicine (Baltimore); 2014 Nov; 93(24):318-332. PubMed ID: 25500701
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical features and prognosis in anti-SRP and anti-HMGCR necrotising myopathy.
    Watanabe Y; Uruha A; Suzuki S; Nakahara J; Hamanaka K; Takayama K; Suzuki N; Nishino I
    J Neurol Neurosurg Psychiatry; 2016 Oct; 87(10):1038-44. PubMed ID: 27147697
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immune-mediated necrotizing myopathy: A comprehensive review of the pathogenesis, clinical features, and treatments.
    Li C; Liu H; Yang L; Liu R; Yin G; Xie Q
    J Autoimmun; 2024 Sep; 148():103286. PubMed ID: 39033686
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autoimmune myopathies: autoantibodies, phenotypes and pathogenesis.
    Mammen AL
    Nat Rev Neurol; 2011 Jun; 7(6):343-54. PubMed ID: 21654717
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autoantibodies in polymyositis and dermatomyositis.
    Ghirardello A; Bassi N; Palma L; Borella E; Domeneghetti M; Punzi L; Doria A
    Curr Rheumatol Rep; 2013 Jun; 15(6):335. PubMed ID: 23591825
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [How can we diagnose and better understand inflammatory myopathies? The usefulness of auto-antibodies].
    Sibilia J; Chatelus E; Meyer A; Gottenberg JE; Sordet C; Goetz J
    Presse Med; 2010 Oct; 39(10):1010-25. PubMed ID: 20655695
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RIG-I expression in perifascicular myofibers is a reliable biomarker of dermatomyositis.
    Suárez-Calvet X; Gallardo E; Pinal-Fernandez I; De Luna N; Lleixà C; Díaz-Manera J; Rojas-García R; Castellví I; Martínez MA; Grau JM; Selva-O'Callaghan A; Illa I
    Arthritis Res Ther; 2017 Jul; 19(1):174. PubMed ID: 28738907
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical characteristics of Vietnamese patients with idiopathic inflammatory myopathies and autoantibodies to aminoacyl-transfer RNA synthetases.
    Phuong TNT; Ngoc LNT; Rönnelid J; Padyukov L; Lundberg IE
    Int J Rheum Dis; 2021 May; 24(5):663-670. PubMed ID: 33788398
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.